About Marburg Virus
The Marburg virus, part of the Filoviridae family, is a highly virulent pathogen closely related to the Ebola virus. Discovered in 1967 during outbreaks in Marburg and Frankfurt, Germany, and Belgrade, Serbia, it causes a rare but severe hemorrhagic fever in humans. The virus is primarily transmitted to humans from fruit bats, specifically the Rousettus aegyptiacus species, and can spread between individuals through direct contact with bodily fluids, contaminated surfaces, or infected tissues. In healthcare settings, transmission can also occur due to insufficient protective measures, making it crucial for medical staff to follow stringent infection control protocols.
Symptoms of Marburg Virus
The Marburg virus typically has an incubation period of 2-21 days, with symptoms appearing suddenly. Initial symptoms are often flu-like, including high fever, severe headache, and muscle pain. As the infection progresses, patients may experience abdominal pain, diarrhea, nausea, vomiting, and extreme fatigue. This phase is often followed by more severe symptoms, including jaundice, liver dysfunction, pancreatitis, and hemorrhagic manifestations, such as bleeding from the gums, nose, or gastrointestinal tract. Advanced cases may lead to shock, multi-organ failure, and even death, highlighting the importance of early intervention and specialized care.
Causes of Marburg Virus Disease
Marburg virus disease is caused by infection with the Marburg virus, which primarily originates in fruit bats. Human infections can occur through prolonged exposure to caves or mines inhabited by these bats. Secondary human-to-human transmission can occur through direct contact with the blood, secretions, or other bodily fluids of infected individuals, particularly during healthcare procedures or funerals. The virus can persist in body fluids even after recovery, making it possible for survivors to transmit the virus for weeks to months after symptoms subside. This potential for ongoing transmission emphasizes the need for continued follow-up and supportive measures for survivors and close contacts.
Treatment of Marburg Virus Disease
Currently, there is no specific antiviral treatment or vaccine for Marburg virus disease, making supportive care the mainstay of treatment. Marburg virus includes rigorous supportive care to manage symptoms and prevent complications. This may involve intravenous fluids to maintain hydration, blood products to treat hemorrhaging, and oxygen therapy for respiratory support.
In cases of Marburg infection, isolation and strict infection control measures are critical to preventing the spread.
Frequently Asked Questions
Symptoms typically appear within 2-21 days after exposure and include high fever, severe headache, muscle pain, and extreme fatigue. As the disease progresses, patients may experience abdominal pain, vomiting, diarrhea, and severe bleeding from various parts of the body.
Currently, there is no specific antiviral treatment or vaccine for Marburg virus disease. Treatment is supportive and aims to manage symptoms, such as providing fluids, oxygen, and blood transfusions as needed. Isolation and strict infection control are essential to prevent the virus from spreading.
To reduce the risk of infection, avoid exposure to fruit bats, especially in caves or mines where they roost. In healthcare settings, strict infection control measures, including wearing personal protective equipment (PPE), are critical when treating infected patients. Avoid contact with bodily fluids of infected individuals and thoroughly clean any contaminated surfaces.
If you suspect exposure to the Marburg virus, seek medical help immediately, especially if you experience symptoms like high fever, muscle pain, or bleeding. Inform healthcare providers of any recent travel to affected areas so they can take the necessary precautions and provide appropriate care.
Request an appointment
Please complete the details and we will book you shortly.
Request an appointment
Please complete the details and we will book you shortly.